Cat.#: ACPP-1074
| Despition | Myocilin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1036 | Recombinant Human ANGPTL7 Protein (6×His Tag) (AC1036) | 50 µg | inquiry |
| ACPP-1719 | Human FDFT1 Protein (AC1719) | 2 µg | inquiry |
| ACPP-1558 | Human ALK/P80 Protein (AC1558) | 2 µg | inquiry |
| ACPP-1239 | PDE7B Blocking Peptide (AC1239) | 250 µg | inquiry |
| ACPP-1104 | Human IL 6 Protein (AC1104) | 5 µg | inquiry |
| ACPP-1470 | Human CLTA Protein (AC1470) | 5 µg | inquiry |
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
| ACPP-1828 | Human EPHA2 Protein (AC1828) | 2 µg | inquiry |
| ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg | inquiry |
| ACPP-1014 | Recombinant Human P Cadherin Protein (6×His Tag) (AC1014) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.